Early relapse rate determines further relapse risk: results of a 5-year follow-up study on pediatric CFH-Ab HUS

BACKGROUND: The complement factor H antibody (CFH-Ab)–associated hemolytic uremic syndrome (HUS) forms a distinct subgroup within the complement-mediated HUS disease spectrum. The autoimmune nature of this HUS subgroup implies the potential benefit of a targeted immunosuppressive therapy. Data on lo...

Descripción completa

Detalles Bibliográficos
Autores principales: Hofer, Johannes, Riedl Khursigara, Magdalena, Perl, Markus, Giner, Thomas, Rosales, Alejandra, Cortina, Gerard, Waldegger, Siegfied, Jungraithmayr, Therese, Würzner, Reinhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910231/
https://www.ncbi.nlm.nih.gov/pubmed/33025207
http://dx.doi.org/10.1007/s00467-020-04751-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910231/
https://www.ncbi.nlm.nih.gov/pubmed/33025207
http://dx.doi.org/10.1007/s00467-020-04751-9

Ejemplares similares